Trans Ova Genetics

Trans Ova Genetics is owned by Precigen.

Precigen is one of the...

• Russell 3000.

Precigen is a company listed under the stock ticker PGEN (US).

Precigen has a direct presence in 4 countries.

Precigen has 6 subsidiaries including Aqua Bounty Technologies, Okanagan Specialty Fruits and Oxitec.

They are in:

• Biotechnology86%
• Food14%

View the org chart displaying its 3 main executives

Most searched biographies at Trans Ova Genetics

• David Faber, President
• Jon Schmidt, Chief Technology Officer
• Chad Feenstra, Chief Financial Officer

Create your alert
to follow the executive moves at Trans Ova Genetics.

Precigen has 2,279 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Trans Ova Genetics

Social media about Trans Ova Genetics

• Trans Ova Genetics on Wikipedia, Google News & Yahoo Finance
• Trans Ova Genetics on LinkedIn, Twitter & YouTube

Contact by email its executives including David Faber

Call Trans Ova Genetics at +1 800...

View the org chart

Register to receive your alert

Report an error